Logo image of RMD

RESMED INC (RMD) Stock Fundamental Analysis

NYSE:RMD - New York Stock Exchange, Inc. - US7611521078 - Common Stock - Currency: USD

252.21  +0.85 (+0.34%)

After market: 252.21 0 (0%)

Fundamental Rating

7

Taking everything into account, RMD scores 7 out of 10 in our fundamental rating. RMD was compared to 503 industry peers in the Health Care Equipment & Supplies industry. RMD has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. RMD has a decent growth rate and is not valued too expensively. These ratings could make RMD a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

RMD had positive earnings in the past year.
RMD had a positive operating cash flow in the past year.
Each year in the past 5 years RMD has been profitable.
Each year in the past 5 years RMD had a positive operating cash flow.
RMD Yearly Net Income VS EBIT VS OCF VS FCFRMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

1.2 Ratios

RMD has a Return On Assets of 17.36%. This is amongst the best in the industry. RMD outperforms 97.34% of its industry peers.
The Return On Equity of RMD (23.68%) is better than 95.21% of its industry peers.
RMD has a better Return On Invested Capital (19.73%) than 98.40% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for RMD is above the industry average of 13.70%.
The 3 year average ROIC (17.61%) for RMD is below the current ROIC(19.73%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 17.36%
ROE 23.68%
ROIC 19.73%
ROA(3y)14.48%
ROA(5y)13.41%
ROE(3y)21.97%
ROE(5y)21.45%
ROIC(3y)17.61%
ROIC(5y)17.76%
RMD Yearly ROA, ROE, ROICRMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

RMD's Profit Margin of 26.15% is amongst the best of the industry. RMD outperforms 95.74% of its industry peers.
RMD's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 32.10%, RMD belongs to the top of the industry, outperforming 99.47% of the companies in the same industry.
RMD's Operating Margin has improved in the last couple of years.
RMD has a Gross Margin (58.76%) which is in line with its industry peers.
In the last couple of years the Gross Margin of RMD has remained more or less at the same level.
Industry RankSector Rank
OM 32.1%
PM (TTM) 26.15%
GM 58.76%
OM growth 3Y0.96%
OM growth 5Y3.9%
PM growth 3Y13.65%
PM growth 5Y7.02%
GM growth 3Y-0.59%
GM growth 5Y-0.23%
RMD Yearly Profit, Operating, Gross MarginsRMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), RMD is creating value.
Compared to 1 year ago, RMD has about the same amount of shares outstanding.
Compared to 5 years ago, RMD has more shares outstanding
The debt/assets ratio for RMD has been reduced compared to a year ago.
RMD Yearly Shares OutstandingRMD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
RMD Yearly Total Debt VS Total AssetsRMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 13.78 indicates that RMD is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 13.78, RMD belongs to the best of the industry, outperforming 91.49% of the companies in the same industry.
The Debt to FCF ratio of RMD is 0.43, which is an excellent value as it means it would take RMD, only 0.43 years of fcf income to pay off all of its debts.
RMD has a Debt to FCF ratio of 0.43. This is amongst the best in the industry. RMD outperforms 94.15% of its industry peers.
RMD has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
RMD has a Debt to Equity ratio (0.12) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 0.43
Altman-Z 13.78
ROIC/WACC2.22
WACC8.89%
RMD Yearly LT Debt VS Equity VS FCFRMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 3.41 indicates that RMD has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.41, RMD is in the better half of the industry, outperforming 60.11% of the companies in the same industry.
RMD has a Quick Ratio of 2.49. This indicates that RMD is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of RMD (2.49) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.41
Quick Ratio 2.49
RMD Yearly Current Assets VS Current LiabilitesRMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.24% over the past year.
The Earnings Per Share has been growing by 16.19% on average over the past years. This is quite good.
Looking at the last year, RMD shows a quite strong growth in Revenue. The Revenue has grown by 9.54% in the last year.
Measured over the past years, RMD shows a quite strong growth in Revenue. The Revenue has been growing by 12.44% on average per year.
EPS 1Y (TTM)25.24%
EPS 3Y13.19%
EPS 5Y16.19%
EPS Q2Q%11.27%
Revenue 1Y (TTM)9.54%
Revenue growth 3Y13.59%
Revenue growth 5Y12.44%
Sales Q2Q%7.92%

3.2 Future

The Earnings Per Share is expected to grow by 12.55% on average over the next years. This is quite good.
The Revenue is expected to grow by 8.51% on average over the next years. This is quite good.
EPS Next Y24%
EPS Next 2Y16.99%
EPS Next 3Y14.53%
EPS Next 5Y12.55%
Revenue Next Year9.42%
Revenue Next 2Y8.59%
Revenue Next 3Y8.11%
Revenue Next 5Y8.51%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
RMD Yearly Revenue VS EstimatesRMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
RMD Yearly EPS VS EstimatesRMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 27.78, which means the current valuation is very expensive for RMD.
Based on the Price/Earnings ratio, RMD is valued a bit cheaper than 76.06% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.60. RMD is around the same levels.
The Price/Forward Earnings ratio is 23.84, which indicates a rather expensive current valuation of RMD.
Compared to the rest of the industry, the Price/Forward Earnings ratio of RMD indicates a somewhat cheap valuation: RMD is cheaper than 74.47% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.39. RMD is around the same levels.
Industry RankSector Rank
PE 27.78
Fwd PE 23.84
RMD Price Earnings VS Forward Price EarningsRMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

75.00% of the companies in the same industry are more expensive than RMD, based on the Enterprise Value to EBITDA ratio.
RMD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. RMD is cheaper than 85.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.71
EV/EBITDA 20.09
RMD Per share dataRMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
RMD has an outstanding profitability rating, which may justify a higher PE ratio.
RMD's earnings are expected to grow with 14.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.16
PEG (5Y)1.72
EPS Next 2Y16.99%
EPS Next 3Y14.53%

6

5. Dividend

5.1 Amount

RMD has a yearly dividend return of 0.85%, which is pretty low.
Compared to an average industry Dividend Yield of 2.39, RMD pays a better dividend. On top of this RMD pays more dividend than 91.49% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, RMD's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.85%

5.2 History

The dividend of RMD has a limited annual growth rate of 5.38%.
RMD has been paying a dividend for at least 10 years, so it has a reliable track record.
RMD has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)5.38%
Div Incr Years12
Div Non Decr Years12
RMD Yearly Dividends per shareRMD Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

23.14% of the earnings are spent on dividend by RMD. This is a low number and sustainable payout ratio.
RMD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP23.14%
EPS Next 2Y16.99%
EPS Next 3Y14.53%
RMD Yearly Income VS Free CF VS DividendRMD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
RMD Dividend Payout.RMD Dividend Payout, showing the Payout Ratio.RMD Dividend Payout.PayoutRetained Earnings

RESMED INC

NYSE:RMD (6/12/2025, 8:27:50 PM)

After market: 252.21 0 (0%)

252.21

+0.85 (+0.34%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-23 2025-04-23/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners62.76%
Inst Owner Change3.49%
Ins Owners0.67%
Ins Owner Change-1.42%
Market Cap36.98B
Analysts74.78
Price Target265.77 (5.38%)
Short Float %7.51%
Short Ratio9.89
Dividend
Industry RankSector Rank
Dividend Yield 0.85%
Yearly Dividend1.92
Dividend Growth(5Y)5.38%
DP23.14%
Div Incr Years12
Div Non Decr Years12
Ex-Date05-08 2025-05-08 (0.53)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.68%
Min EPS beat(2)-0.57%
Max EPS beat(2)3.93%
EPS beat(4)2
Avg EPS beat(4)2.47%
Min EPS beat(4)-0.57%
Max EPS beat(4)6.87%
EPS beat(8)5
Avg EPS beat(8)2.23%
EPS beat(12)8
Avg EPS beat(12)2.04%
EPS beat(16)10
Avg EPS beat(16)1.55%
Revenue beat(2)1
Avg Revenue beat(2)-0.2%
Min Revenue beat(2)-0.56%
Max Revenue beat(2)0.16%
Revenue beat(4)2
Avg Revenue beat(4)0.46%
Min Revenue beat(4)-0.56%
Max Revenue beat(4)2.73%
Revenue beat(8)4
Avg Revenue beat(8)0.07%
Revenue beat(12)6
Avg Revenue beat(12)0.61%
Revenue beat(16)8
Avg Revenue beat(16)0.65%
PT rev (1m)-0.96%
PT rev (3m)-2.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.1%
EPS NY rev (1m)0.54%
EPS NY rev (3m)0.45%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)0.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE 27.78
Fwd PE 23.84
P/S 7.36
P/FCF 23.71
P/OCF 22.37
P/B 6.67
P/tB 16.31
EV/EBITDA 20.09
EPS(TTM)9.08
EY3.6%
EPS(NY)10.58
Fwd EY4.19%
FCF(TTM)10.64
FCFY4.22%
OCF(TTM)11.27
OCFY4.47%
SpS34.25
BVpS37.82
TBVpS15.46
PEG (NY)1.16
PEG (5Y)1.72
Profitability
Industry RankSector Rank
ROA 17.36%
ROE 23.68%
ROCE 24.33%
ROIC 19.73%
ROICexc 22.96%
ROICexgc 54.14%
OM 32.1%
PM (TTM) 26.15%
GM 58.76%
FCFM 31.06%
ROA(3y)14.48%
ROA(5y)13.41%
ROE(3y)21.97%
ROE(5y)21.45%
ROIC(3y)17.61%
ROIC(5y)17.76%
ROICexc(3y)18.48%
ROICexc(5y)19.04%
ROICexgc(3y)42.98%
ROICexgc(5y)49.28%
ROCE(3y)21.71%
ROCE(5y)21.9%
ROICexcg growth 3Y-8.9%
ROICexcg growth 5Y-1.39%
ROICexc growth 3Y-2.46%
ROICexc growth 5Y5.3%
OM growth 3Y0.96%
OM growth 5Y3.9%
PM growth 3Y13.65%
PM growth 5Y7.02%
GM growth 3Y-0.59%
GM growth 5Y-0.23%
F-Score8
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 0.43
Debt/EBITDA 0.36
Cap/Depr 43.09%
Cap/Sales 1.86%
Interest Coverage 58.78
Cash Conversion 90.41%
Profit Quality 118.77%
Current Ratio 3.41
Quick Ratio 2.49
Altman-Z 13.78
F-Score8
WACC8.89%
ROIC/WACC2.22
Cap/Depr(3y)67.15%
Cap/Depr(5y)68.87%
Cap/Sales(3y)3.33%
Cap/Sales(5y)3.44%
Profit Quality(3y)71.12%
Profit Quality(5y)91.2%
High Growth Momentum
Growth
EPS 1Y (TTM)25.24%
EPS 3Y13.19%
EPS 5Y16.19%
EPS Q2Q%11.27%
EPS Next Y24%
EPS Next 2Y16.99%
EPS Next 3Y14.53%
EPS Next 5Y12.55%
Revenue 1Y (TTM)9.54%
Revenue growth 3Y13.59%
Revenue growth 5Y12.44%
Sales Q2Q%7.92%
Revenue Next Year9.42%
Revenue Next 2Y8.59%
Revenue Next 3Y8.11%
Revenue Next 5Y8.51%
EBIT growth 1Y25.05%
EBIT growth 3Y14.69%
EBIT growth 5Y16.83%
EBIT Next Year31.4%
EBIT Next 3Y15.73%
EBIT Next 5Y12.52%
FCF growth 1Y282.58%
FCF growth 3Y27.55%
FCF growth 5Y27.5%
OCF growth 1Y208.76%
OCF growth 3Y23.9%
OCF growth 5Y25%